Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases Read more
Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH Read more
Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program Read more
OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy Read more